Medical Therapy for Crohn's Disease: The State of the Art
- 1 February 2001
- journal article
- review article
- Published by Elsevier in Surgical Clinics of North America
- Vol. 81 (1) , 71-101
- https://doi.org/10.1016/s0039-6109(05)70274-7
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's diseaseDigestive Diseases and Sciences, 1992
- Risk-Benefit Assessment of Drugs Used in the Treatment of Inflammatory Bowel DiseaseDrug Safety, 1991
- A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's DiseaseNew England Journal of Medicine, 1989
- Immunosuppressive Drugs in Inflammatory Bowel DiseaseDrugs, 1989
- Favorable effect of 6-Mercaptopurine on fistulae of Crohn's diseaseDigestive Diseases and Sciences, 1985
- SulfasalazineDigestive Diseases and Sciences, 1983
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980
- A controlled trial of azathioprine in Crohn's diseaseDigestive Diseases and Sciences, 1975